Biosimilar Newsletter Archive

  1. 09.20.18 -- 4 Revelations From FDA's Part 15 Hearing
    9/20/2018

    09/20/18 Biosimilar Development Newsletter

  2. 09.13.18 -- Are Biosimilars Brazil's Waterloo?
    9/13/2018

    09/13/18 Biosimilar Development Newsletter

  3. 09.12.18 -- How Automation Accelerates Biosimilar Manufacturing With Flexibility And Efficiency
    9/12/2018
    09/12/18 Biosimilar Development Newsletter
  4. 09.06.18 -- The Great Canadian Biosimilar Transition
    9/6/2018

    09/06/18 Biosimilar Development Newsletter

  5. 08.30.18 -- Can Biosimilars Conquer The "Emotional Hurdle?"
    8/30/2018

    08/30/18 Biosimilar Development Newsletter

  6. 08.23.18 -- Biosimilar Value: The Devil Is In The Details
    8/23/2018

    08/23/18 Biosimilar Development Newsletter

  7. 08.16.18 -- What To Watch In The Biosimilar Regulatory Space
    8/16/2018

    08/16/18 Biosimilar Development Newsletter

  8. 08.09.18 -- EU Turns Focus To Biosimilar Sustainability Questions
    8/9/2018

    08/09/18 Biosimilar Development Newsletter

  9. 08.07.18 -- Speed To Market Strategies For Biosimilar Manufacturers
    8/7/2018
    08/07/18 Biosimilar Development Newsletter
  10. 08.02.18 -- Samsung Bioepis: From Biosimilars To Novel Biologics
    8/2/2018

    08/02/18 Biosimilar Development Newsletter